XML 28 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock-based Compensation | 9 Months Ended
--- | ---
Oct. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Stock-based Compensation | 11. Stock-based Compensation The following table presents the classification of stock-based compensation for the periods indicated:
|  | Three Months Ended October 31, |  |  | Nine Months Ended October 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands) |
Stock-based compensation: |  |  |  |  |  |  |  |  |  |  |  |
Cost of revenue |  | $ | 658 |  |  | $ | 899 |  |  | $ | 2,389 |  |  | $ | 2,339 |
Research and development |  |  | 16,776 |  |  |  | 18,637 |  |  |  | 51,333 |  |  |  | 54,653 |
Selling, general and administrative |  |  | 8,307 |  |  |  | 7,311 |  |  |  | 23,337 |  |  |  | 23,503 |
Total stock-based compensation |  | $ | 25,741 |  |  | $ | 26,847 |  |  | $ | 77,059 |  |  | $ | 80,495 |
As of October 31, 2025, approximately $5.6 million of stock-based compensation expense was accrued in accrued and other current liabilities in the condensed consolidated balance sheets. Total unrecognized compensation cost related to unvested restricted stock units at October 31, 2025 was approximately $175.1 million and is expected to be recognized over a weighted-average period of 2.52 years. Total unrecognized compensation cost related to unvested stock options at October 31, 2025 was immaterial. The following table sets forth the weighted-average assumptions used to estimate the fair value of employee stock purchase plan awards for the periods indicated:
|  | Three Months Ended October 31, |  |  | Nine Months Ended October 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Employee stock purchase plan awards: |  |  |  |  |  |  |  |  |  |  |  |
Volatility |  |  | 68 | % |  |  | 56 | % |  |  | 61 | % |  |  | 47 | %
Risk-free interest rate |  |  | 3.81 | % |  |  | 4.55 | % |  |  | 4.05 | % |  |  | 4.97 | %
Expected term (years) |  | 0.5 |  |  | 0.5 |  |  | 0.5 |  |  | 0.5 |
Dividend yield |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | %
The following table summarizes stock option activities for the period indicated:
|  | Options Outstanding |
|  |  |  |  |  |  |  |  |  |  |  |  | Weighted- |  |  |  |
|  |  |  |  |  |  |  |  |  | Total Intrinsic |  |  | Average |  |  |  |
|  |  |  |  |  |  |  | Weighted- |  | Value Of |  |  | Remaining |  |  | Aggregate |
|  |  |  |  | Weighted- |  |  | Average |  | Options |  |  | Contractual |  |  | Intrinsic |
|  |  |  |  | Average |  |  | Grant-date |  | Exercised |  |  | Term |  |  | Value |
|  | Shares |  |  | Exercise Price |  |  | Fair Value |  | (in thousands) |  |  | (in years) |  |  | (in thousands) |
Outstanding at January 31, 2025 |  |  | 226,616 |  |  | $ | 52.20 |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | (47,641 | ) |  |  | 43.40 |  |  |  |  | $ | 1,615 |  |  |  |  |  |  |
Expired |  |  | (16,619 | ) |  |  | 75.00 |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at October 31, 2025 |  |  | 162,356 |  |  |  | 52.45 |  |  |  |  |  |  |  |  | 2.26 |  |  | $ | 5,556 |
Exercisable at October 31, 2025 |  |  | 162,343 |  |  | $ | 52.46 |  |  |  |  |  |  |  |  | 2.26 |  |  | $ | 5,555 |
The intrinsic value of options outstanding and exercisable is calculated based on the difference between the fair market value of the Company’s ordinary shares on the reporting date and the exercise price. The closing price of the Company’s ordinary shares on October 31, 2025 was $85.23, as reported by The Nasdaq Global Select Market. The intrinsic value of exercised options is calculated based on the difference between the fair market value of the Company’s ordinary shares on the exercise date and the exercise price. The following table summarizes restricted stock unit activities for the period indicated:
|  |  |  |  | Weighted- |
|  |  |  |  | Average |
|  |  |  |  | Grant-Date |
|  | Shares |  |  | Fair Value |
Unvested at January 31, 2025 |  |  | 2,645,379 |  |  | $ | 71.84 |
Granted |  |  | 1,359,268 |  |  |  | 74.30 |
Vested |  |  | (874,684 | ) |  |  | 74.15 |
Forfeited |  |  | (221,545 | ) |  |  | 86.96 |
Unvested at October 31, 2025 |  |  | 2,908,418 |  |  | $ | 71.15 |
As of October 31, 2025, the aggregate intrinsic value of unvested restricted stock units was $247.9 million.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration